FDA Cites SyrmiseAG Over CAPA Violations, Records

Drug Industry Daily
A A
The FDA cited API manufacturer Syrmise of Holzminden, Germany, for eight violations including failure to investigate when a component, intermediate or API did not meet specifications.

To View This Article:

Login

Subscribe To Drug Industry Daily